Market Tracker

07/21 5:16pm ET

Endocyte Inc (NASDAQ:ECYT)

1.43
Delayed Data
As of Jul 21
 +0.01 / +0.70%
Today’s Change
1.36
Today|||52-Week Range
3.49
-43.92%
Year-to-Date

Today’s Trading

Previous close1.42
Today’s open1.41
Day’s range1.41 - 1.44
Volume214,064
Average volume (3 months)516,724
Market cap$60.7M
Dividend yield--
Data as of 4:00pm ET, 07/21/2017

Growth & Valuation

Earnings growth (last year)-6.12%
Earnings growth (this year)+14.90%
Earnings growth (next 5 years)--
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales1,537.67
Price/Book0.44

Competitors

 Today’s
change
Today’s
% change
AGLEAeglea Bio Therapeut...+0.08+2.21%
XENEXenon Pharmaceutical...+0.05+1.52%
ATXIAvenue Therapeutics ...-0.15-2.04%
NBYNovaBay Pharmaceutic...0.000.00%
Data as of 4:00pm ET, 07/21/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$70.0K
Annual profit (last year)-$43.9M
Net profit margin-62,696.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Sherman
Chief Financial Officer
Michael T. Andriole
Corporate headquarters
West Lafayette, Indiana

Forecasts